Not logged in Share Save
Share Save
Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial Barlesi, Fabrice; Ahn, Jin Seok; Solomon, Benjamin J.; Nishio, Makoto; Dziadziuszko, Rafal; Lee, Dae Ho; Lee, Jong-Seok; Zhong, Wenzhao; Horinouchi, Hidehito; Mao, Weimin; Hochmair, Maximilian; de Marinis, Filippo; Migliorino, Maria Rita; Bondarenko, Igor; Xu, Tingting; Bara, Ilze; Ding, Beiying; Ngiam, Celina; Petric, Patricia; Wu, Yi-Long Share Save
Share Save
Plain language summary of the ALINA study results: alectinib compared with chemotherapy after surgery in people with ALK-positive non-small cell lung cancer Wu, Yi-Long; Dziadziuszko, Rafal; Ahn, Jin Seok; Barlesi, Fabrice; Nishio, Makoto; Lee, Dae Ho; Lee, Jong-Seok; Zhong, Wenzhao; Horinouchi, Hidehito; Mao, Weimin; Hochmair, Maximilian; De Marinis, Filippo; Migliorino, Maria Rita; Bondarenko, Igor; Lu, Shun; Wang, Qun; Lohmann, Tania Ochi; Xu, Tingting; Cardona, Andres; Hiles, Laura; Noe, Johannes; Solomon, Benjamin J. Share Save
Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial Ahn, Myung-Ju; Delmonte, Angelo; Ghosh, Sharmistha; Hochmair, Maximilian; Yang, Tsung-Ying; Yang, James Chih-Hsin; Han, Ji-Youn; Hansen, Karin Holmskov; Wu, Yanyu; Wan, Yin; Lin, Huamao Mark; Kretz, Julian; Hupf, Bradley; Kurec, Ahmet Melih; Churchill, Eric N.; Fram, Robert J.; Cabasag, Citadel Jungco; Goriya, Vishal; Zhao, Yuzhe; Campelo, Maria Rosario Garcia Share Save
Share Save
Share Save
Share Save
Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous NSCLC That Responded to First-Line Pembrolizumab Plus Chemotherapy Hochmair, Maximilian; Schenker, Michael; Dols, Manuel Cobo; Kim, Tae Min; Ozyilkan, Ozgur; Smagina, Maria; Leonova, Viktoriya; Kato, Terufumi; Fedenko, Alexander; De Angelis, Flavia; Rittmeyer, Achim; Gray, Jhanelle E.; Greystoke, Alastair; Aggarwal, Himani; Huang, Qinlei; Zhao, Bin; Lara-Guerra, Humberto; Nadal, Ernest Share Save
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer Skoulidis, Ferdinandos; Li, Bob T.; Hochmair, Maximilian; Govindan, Ramaswamy; Vincent, Mark; van der Wekken, Anthonie J.; Reguart Aransay, Noemi; O'Byrne, Kenneth J.; Griesinger, Frank; Nishio, Makoto; Lindsay, Colin; Reinmuth, Niels; Paulus, Astrid; Papakotoulas, Pavlos; Kim, Sang-We; Ferreira, Carlos Gil; Pasello, Giulia; Duruisseaux, Michael; Gennatas, Spyridon; Dimou, Anastasios; Mehta, Bhakti; Kormany, William; Nduka, Chidozie; Sylvester, Brooke E.; Ardito-Abraham, Christine; Wang, Yang; de Langen, Adrianus Johannes Share Save
Share Save
Prognostic Value of PD-L1, BAP-1 and ILK in Pleural Mesothelioma Illini, Oliver; Benej, Michal; Lang-Stoeberl, Anna Sophie; Fabikan, Hannah; Brcic, Luka; Sucher, Florian; Krenbek, Dagmar; Krajc, Tibor; Weinlinger, Christoph; Hochmair, Maximilian J.; Valipour, Arschang; Klikovits, Thomas; Watzka, Stefan Share Save
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy Saalfeld, Felix Carl; Moeller, Johanna; Christopoulos, Petros; Wenzel, Carina; Rasokatf, Anna; Wangg, Xuejun Alice; Vathiotish, Ioannis; Koenigi, David; Illinij, Oliver; Grohe, Christian; Wiesweg, Marcel; Wesseler, Claas; Schubart, Christoph; Pelusi, Natalie; Rohde, Gernot; Overbeck, Tobias R.; Kirfel, Jutta; Alt, Juergen; Kauffmann-Guerrero, Diego; Griesingerv, Frank; Kulhavyw, Jonas; Allgaeuer, Michael; Klimovay, Anna; Schuetz, Maret; Aust, Daniela E.; Hochmairj, Maximilian J.; Rothschild, Sacha I.; Syrigos, Konstantinos N.; Veluswamy, Rajwanth; Michels, Sebastian; Stenzinger, Albrecht; Joehrens, Korinna; Wermke, Martin Share Save
Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo) Kao, S. C-H.; Reck, M.; Liu, S. V.; Dziadziuszko, R.; Hochmair, M. J.; Huemer, F.; Gilberto de Castro, J.; Bernabe Caro, R.; Kim, S. H.; Kowalski, D. M.; Andric, Z. G.; Oancea, M.; Kaul, M.; Li, H.; Danner, B.; Lee, M. C.; Nabet, B. Y.; Sugawara, S. Share Save
Share Save
Prognostic impact of targetable driver alterations in resected early-stage lung cancer Terbuch, Angelika; Konjic, Selma; Schlintl, Verena; Absenger, Gudrun; Jost, Philipp J.; Lindenmann, Joerg; Swatek, Paul; John, Nikolaus; John, Teresa; Wurm, Robert; Zacharias, Martin; Posch, Florian; Hochmair, Maximilian J.; Fabikan, Hannah; Weinlinger, Christoph; Illini, Oliver; Horvath, Lena; Gamerith, Gabriele; Wolf, Dominik; Augustin, Florian; Brcic, Luka Share Save
Real-world NGS testing results and treatment modalities in lung cancer: Data update from LALUCA - Landsteiner Lung Cancer Research Platform Lang-Stoeberl, Anna; Rodriguez, Vania Mikaela; Rosenthaler, David; Fabikan, Hannah; Weinlinger, Christoph; Hochmair, Maximilian; Illini, Oliver; Krenbek, Dagmar; Kirchbacher, Klaus; Mueser, Nino; Funk, Georg-Christian; Valipour, Arschang Share Save
Adenosquamous Carcinoma of the Lung: Survival, Radiologic Findings, PD-L1, and Driver Mutations Illini, Oliver; Fabikan, Hannah; Fischer, Eva; Lang-Stoeberl, Anna Sophie; Krenbek, Dagmar; Jarius, Christa; Azarnia-Medan, Shokoufa; Gasser, Stefan; Hochmair, Maximilian Johannes; Weinlinger, Christoph; Valipour, Arschang; Watzka, Stefan Share Save
Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC Hochmair, Maximilian J.; Vermaelen, Karim; Mountzios, Giannis; Carcereny, Enric; Dooms, Christophe; Lee, Se-Hoon; Morocz, Eva; Kato, Terufumi; Ciuleanu, Tudor-Eliade; Dy, Grace K.; Parente, Barbara; O'Byrne, Kenneth J.; Chu, Quincy S.; De Castro Junior, Gilberto; Girard, Nicolas; Snyder, Wendy; Tran, Qui; Kormany, William; Houk, Brett; Mehta, Bhakti; Curioni-Fontecedro, Alessandra Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
